UNC Lineberger researchers to share data, expertise at 61st ASH Annual Meeting

December 6, 2019

University of North Carolina Lineberger Comprehensive Cancer Center researchers will be well-represented at the 61st American Society of Hematology Annual Meeting in Orlando, Florida, Dec. 7-10. ASH is the world’s largest professional society of hematologists and is dedicated to understanding, diagnosing, treating and preventing blood disorders. The society expects more than 20,000 hematologists and health … Continued

Mirlekar named recipient of Society for Immunotherapy of Cancer’s 2019 Young Investigator Award

November 18, 2019

The Society for Immunotherapy of Cancer honored Rahul Mirlekar, PhD, a postdoctoral research associate at UNC Lineberger, as a recipient of its 2019 Young Investigator Award. The society honored Mirlekar at its 34th Annual Meeting, held Nov. 6-10 in National Harbor, Maryland. The meeting was expected to attract more than 4,000 researchers, clinicians, pharmacists and … Continued

Scientists publish overview of the latest in cancer vaccine target research

July 12, 2019

University of North Carolina Lineberger Comprehensive Cancer Center researchers have published a review of experimental cancer vaccines that identified areas of promise and challenges for the field. In the Nature Reviews Cancer, researchers outlined current research into targets for therapeutic cancer vaccines, an area of active investigation focused on boosting immune responses to cancer. “Generally, … Continued

Wang and Serody awarded $2M grant to study personalized cancer vaccines

December 3, 2018

The University of North Carolina System recently awarded UNC Lineberger’s Andrew Wang, MD, and Jonathan Serody, MD, a four year, $2.09 million Research Opportunities Initiative grant to support their research using pharmacoengineering approaches to develop more effective personalized cancer vaccines. The grant was one of 15 awarded to scientists across the UNC System, with the specific intent to support … Continued